These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24024751)

  • 1. Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson's disease, using mito-TEMPO.
    Zhelev Z; Bakalova R; Aoki I; Lazarova D; Saga T
    ACS Chem Neurosci; 2013 Nov; 4(11):1439-45. PubMed ID: 24024751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging of Mitochondrial Dysfunction and Metabolic Activity, Accompanied by Overproduction of Superoxide.
    Bakalova R; Georgieva E; Ivanova D; Zhelev Z; Aoki I; Saga T
    ACS Chem Neurosci; 2015 Dec; 6(12):1922-9. PubMed ID: 26367059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue redox activity as a sensing platform for imaging of cancer based on nitroxide redox cycle.
    Zhelev Z; Aoki I; Gadjeva V; Nikolova B; Bakalova R; Saga T
    Eur J Cancer; 2013 Apr; 49(6):1467-78. PubMed ID: 23265713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
    Sharma A; Kaur P; Kumar V; Gill KD
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
    Kim HG; Ju MS; Kim DH; Hong J; Cho SH; Cho KH; Park W; Lee EH; Kim SY; Oh MS
    Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):958-64. PubMed ID: 20629656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum.
    Thomas B; Mohanakumar KP
    J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.
    Rojo AI; Montero C; Salazar M; Close RM; Fernández-Ruiz J; Sánchez-González MA; de Sagarra MR; Jackson-Lewis V; Cavada C; Cuadrado A
    Eur J Neurosci; 2006 Oct; 24(7):1874-84. PubMed ID: 17067291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease.
    Huh SH; Chung YC; Piao Y; Jin MY; Son HJ; Yoon NS; Hong JY; Pak YK; Kim YS; Hong JK; Hwang O; Jin BK
    J Immunol; 2011 Jul; 187(2):960-9. PubMed ID: 21685323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
    Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
    J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin Represses C/EBP
    Lei K; Shen Y; He Y; Zhang L; Zhang J; Tong W; Xu Y; Jin L
    Oxid Med Cell Longev; 2020; 2020():8951907. PubMed ID: 32566108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
    Pennathur S; Jackson-Lewis V; Przedborski S; Heinecke JW
    J Biol Chem; 1999 Dec; 274(49):34621-8. PubMed ID: 10574926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice.
    Purushothuman S; Nandasena C; Peoples CL; El Massri N; Johnstone DM; Mitrofanis J; Stone J
    J Parkinsons Dis; 2013; 3(1):77-83. PubMed ID: 23938314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.